Many labs consider themselves automated, but manual steps persist. Here’s where automation is working, where it’s falling short, and how some labs are starting to close the gaps.
Read More
Personalis presented data at AACR showing its NeXT Personal assay enabled ultrasensitive ctDNA monitoring for colorectal and lung cancer patients, demonstrating 100% sensitivity at baseline and 100% specificity for relapse post-surgery.
Read More
A study reports that CSF liquid biopsy measuring variant allele frequency may improve leptomeningeal disease diagnosis, especially when MRI and cytology are inconclusive.
Read More
Ultima Genomics presented data at AACR 2026 showing its ppmSeq technology detected circulating tumor DNA at low single-digit parts-per-million in a TRACERx pilot of 50 plasma samples.
Read More
TCM Biotech has received FDA Breakthrough Device Designation for CatCHimera, a liquid biopsy platform for monitoring minimal residual disease in hepatocellular carcinoma using HBV–host genome integration biomarkers.
Read More